Previous close | 0.7400 |
Open | 0.7000 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.6895 - 0.7500 |
52-week range | 0.5222 - 2.6150 |
Volume | |
Avg. volume | 19,177 |
Market cap | 2.813M |
Beta (5Y monthly) | 2.74 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.2600 |
Earnings date | 15 Apr 2024 - 19 Apr 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
MIAMI, March 06, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 68th Emerging Growth Conference on March 6 & 7, 2024. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting compani
Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the Emerging Growth Conference on March 7, 2024 (https://emerginggrowth.com/conference/).
MIAMI, Feb. 06, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 67th Emerging Growth Conference on February 7 & 8, 2024. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting compa